" class="no-js "lang="en-US"> Recursion - Medtech Alert
Tuesday, September 30, 2025
Recursion | Pharmtech Focus

Recursion

About Recursion

Recursion

We are a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery.

We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded.

While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt Lake City.

Related Story

Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery

June 24 2021

Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, […]